Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats

L E Vinge1, E Øie, Y Andersson

  • 1Institute for Surgical Research, Rikshospitalet University Hospital, University of Oslo, N-0027 Oslo, Norway.

Insights

Congestive heart failure (CHF) involves G protein-coupled receptor kinase 2 (GRK2). This study investigated GRK and arrestin isoforms in rat hearts, finding GRK2, GRK5, and beta-arrestin-1 increase in failing hearts.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Signaling

Background:

  • G protein-coupled receptor kinases (GRKs) and arrestins are crucial in regulating G protein-coupled receptor (GPCR) signaling.
  • GRK2 is implicated in the pathophysiology of congestive heart failure (CHF).
  • The specific cellular distribution of GRK and arrestin isoforms within myocardial tissue in CHF remains largely uncharacterized.

Purpose of the Study:

  • To investigate the myocardial expression and cellular distribution of different G protein-coupled receptor kinase (GRK) and arrestin isoforms in a rat model of congestive heart failure (CHF).
  • To determine the changes in mRNA and protein levels of these isoforms following myocardial infarction.
  • To elucidate the specific cellular localization of these key signaling proteins within the heart.

Main Methods:

  • Induction of myocardial infarction in rats via left coronary artery ligation, with sham-operated controls.
  • Euthanasia at 2, 7, and 42 days post-surgery.
  • Quantitative assessment of myocardial GRK2, GRK5, GRK3, beta-arrestin-1, and beta-arrestin-2 mRNA levels using RT-PCR.
  • Western blot analysis of protein expression in myocardial tissue extracts.
  • Immunohistochemical analysis of myocardial tissue sections and isolated cells to determine cellular localization.

Main Results:

  • Myocardial mRNA levels of GRK2, GRK5, beta-arrestin-1, and beta-arrestin-2 were significantly induced in failing hearts compared to sham controls.
  • Western blot analysis confirmed elevated protein levels of GRK2 (3.0-fold), GRK5 (2.6-fold), and beta-arrestin-1 (1.5-fold) at 7 days post-myocardial infarction.
  • Immunohistochemistry revealed GRK2 and beta-arrestin-1 are predominantly localized in endothelial cells, while GRK3 is confined to cardiac myocytes, and GRK5 is homogeneously distributed.

Conclusions:

  • Myocardial expression of GRK2, GRK5, and beta-arrestin-1 is upregulated in post-infarction heart failure in rats.
  • The distinct cellular localization suggests GRK2 and beta-arrestin-1 may primarily regulate endothelial function in the failing heart.
  • GRK3 and GRK5 cellular distribution implicates them as potential regulators of cardiac myocyte function.